News
But rising Chinese import tariffs due to the trade war with the U.S. and longer-term concerns about costs or access are ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
8h
Zacks Investment Research on MSNPFE New & Acquired Drugs Back 1H Top-Line Growth: Will the Trend Last?
With the end of the pandemic, sales of Pfizer’s PFE COVID products, Comirnaty and Paxlovid, have declined from their peak.
Keytruda and Padcev generated promising topline results for those with muscle-invasive bladder cancer who are ineligible for ...
Merck has begun the 8% reduction of its workforce—an initiative that the company revealed two weeks ago—with the dismissal of ...
If you have decades to go before you retire, you want to make sure you own companies that know how to survive and thrive.
Merck’s second quarter performance aligned with Wall Street’s revenue expectations but drew a negative reaction from the ...
Merck & Co., Inc. recently reported robust earnings, yet the market response was lukewarm. Investors overlooked several positive aspects beneath the surface. Unusual expenses, totaling US$4.2 billion, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results